SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001132413-10-000008
Filing Date
2010-03-03
Accepted
2010-03-03 17:13:44
Documents
1
Group Members
INTEGRATED CORE STRATEGIES (US) LLCISRAEL A. ENGLANDERMILLENNIUM MANAGEMENT LLC

Document Format Files

Seq Description Document Type Size
1 jav_sc13d.htm SC 13D 2549722
  Complete submission text file 0001132413-10-000008.txt   2552162
Mailing Address 125 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140
Business Address 125 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140 617-349-4500
JAVELIN PHARMACEUTICALS, INC (Subject) CIK: 0000050710 (see all company filings)

IRS No.: 880471759 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-62367 | Film No.: 10654260
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MILLENNIUM MANAGEMENT LLC 666 FIFTH AVENUE, 8TH FLOOR NEW YORK NY 10103
Business Address C/O MILLENNIUM MANAGEMENT LLC 666 FIFTH AVENUE, 8TH FLOOR NEW YORK NY 10103 (212) 841-4100
MILLENCO LLC (Filed by) CIK: 0001132413 (see all company filings)

IRS No.: 133532932 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D